Hilmi Haleeda, Flanagan Leah, Murphy Eamonn, Bassa Bibi, McDermott Cian
Emergency Medicine, Mater Misericordiae University Hospital, Dublin, IRL.
Cardiology, Mater Misericordiae University Hospital, Dublin, IRL.
Cureus. 2024 Nov 11;16(11):e73419. doi: 10.7759/cureus.73419. eCollection 2024 Nov.
Atrial Fibrillation (AF) is uncommon in pregnancy but associated with significant mortality. Although controlled studies evaluating therapeutic management of AF in pregnancy are lacking, current guidelines suggest that direct current cardioversion (DCCV) is safe in cases of maternal arrhythmia with hemodynamic compromise. In this report, we discuss a female patient of 22 weeks gestation who presented to the non-obstetric Emergency Department (ED) with acute onset, symptomatic AF. Following consultation with emergency medicine, cardiology, and maternal-fetal medicine specialists, rhythm control was favored for immediate management. A single 200 joules synchronized shock resulted in a successful reversion to sinus rhythm with no adverse events using agreed procedural sedation protocols. The patient had an uneventful inpatient course and was later discharged with outpatient cardiology and obstetric follow-up. This case contributes to the evidence that DCCV is safe in pregnant patients and proposes that standard medications used for analgesia and sedation in cardioversion are safe in pregnancy. A multidisciplinary team approach is key in managing AF in pregnancy in the acute non-obstetric setting.
心房颤动(AF)在妊娠期并不常见,但与显著的死亡率相关。尽管缺乏评估妊娠期AF治疗管理的对照研究,但目前的指南表明,在伴有血流动力学损害的母体心律失常病例中,直流电复律(DCCV)是安全的。在本报告中,我们讨论了一名妊娠22周的女性患者,她因急性发作、有症状的AF就诊于非产科急诊科(ED)。在与急诊医学、心脏病学和母胎医学专家会诊后,倾向于立即进行节律控制。使用商定的程序镇静方案,单次200焦耳同步电击成功恢复窦性心律,无不良事件发生。患者住院过程顺利,后来出院,接受门诊心脏病学和产科随访。该病例为DCCV在妊娠患者中安全的证据提供了补充,并表明用于复律的标准镇痛和镇静药物在妊娠期是安全的。在急性非产科情况下,多学科团队方法是管理妊娠期AF的关键。